Jérôme Galon, PhD, presenting the international validation of Immunoscore® Colon for the classification of colon cancer
Stanley Hamilton, MD, opening the symposium dedicated to Immunoscore® Colon clinical utility and its role in early stage colon cancer patients’ management.
Discussion on clinical cases with David Malka, MD, PhD & Marc Van Den Eynde, MD, PhD
Approaches to treat immune hot, altered and cold tumors by Jérôme Galon, Research Director Inserm, Paris
Immunogram proof of concept on CRC samples by Jacques Fieschi, VP R&D HalioDx